ZIOPTAN - 0006-3931-54 - (TAFLUPROST)

Alphabetical Index


Drug Information of ZIOPTAN

Product NDC: 0006-3931
Proprietary Name: ZIOPTAN
Non Proprietary Name: TAFLUPROST
Active Ingredient(s): .0045    mg/.3mL & nbsp;   TAFLUPROST
Administration Route(s): OPHTHALMIC
Dosage Form(s): SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of ZIOPTAN

Product NDC: 0006-3931
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA202514
Marketing Category: NDA
Start Marketing Date: 20120210

Package Information of ZIOPTAN

Package NDC: 0006-3931-54
Package Description: 9 POUCH in 1 CARTON (0006-3931-54) > 10 AMPULE in 1 POUCH (0006-3931-10) > .3 mL in 1 AMPULE

NDC Information of ZIOPTAN

NDC Code 0006-3931-54
Proprietary Name ZIOPTAN
Package Description 9 POUCH in 1 CARTON (0006-3931-54) > 10 AMPULE in 1 POUCH (0006-3931-10) > .3 mL in 1 AMPULE
Product NDC 0006-3931
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name TAFLUPROST
Dosage Form Name SOLUTION
Route Name OPHTHALMIC
Start Marketing Date 20120210
Marketing Category Name NDA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name TAFLUPROST
Strength Number .0045
Strength Unit mg/.3mL
Pharmaceutical Classes Prostaglandin Analog [EPC],Prostaglandin Receptor Agonists [MoA],Increased Prostaglandin Activity [PE],Prostaglandins [Chemical/Ingredient]

Complete Information of ZIOPTAN


General Information